Glutamine: Benefits, Forms, Dosing, and Side Effects

L-glutamine is the most abundant free amino acid in the human body and plasma, serving as a key building block for proteins and a major nitrogen and carbon donor in numerous metabolic pathways [1][2]. It is synthesized primarily in skeletal muscle, liver, and brain via the enzyme glutamine synthetase, and the body produces approximately 50-80 grams per day endogenously. While classified as non-essential under normal conditions, glutamine becomes conditionally essential during trauma, surgery, sepsis, burns, and intense prolonged exercise. This article reviews the full clinical evidence for glutamine supplementation, including its role in gut health, immune function, exercise recovery, chemotherapy support, and critical care.

Table of Contents

• Overview
• Forms and Bioavailability
• Evidence for Benefits
• Recommended Dosing
• Safety and Side Effects
• Drug Interactions
• Dietary Sources
• References

Overview

L-glutamine is the most abundant free amino acid in the human body and plasma, serving as a key building block for proteins and a major nitrogen and carbon donor in numerous metabolic pathways [1][2]. It is synthesized primarily in skeletal muscle, liver, and brain via the enzyme glutamine synthetase, which catalyzes the ATP-dependent amidation of glutamate with ammonia [2][3]. Because the body can produce it endogenously — at a rate of approximately 50-80 grams per day — glutamine is classified as a non-essential amino acid under normal physiological conditions [1][2][3].

However, glutamine becomes conditionally essential during periods of physiological stress such as trauma, surgery, sepsis, burns, and intense prolonged exercise, when demand exceeds endogenous production capacity [1][2][4]. During these catabolic states, glutamine requirements can increase up to threefold, and skeletal muscle stores — which serve as the body's primary glutamine reservoir — may become depleted [4][5]. Plasma glutamine levels typically range from 500-750 micromolar under normal conditions but can fall significantly during critical illness [5][6].

Glutamine participates in a remarkably diverse array of biological functions [1][2][3]:

• Cellular energy production: Glutamine is a primary fuel source for rapidly dividing cells, including enterocytes (intestinal lining cells), immune cells (lymphocytes, macrophages, neutrophils), and renal tubular cells. Enterocytes alone extract approximately 30 grams of glutamine per day from the circulation [3][7].
• Gut barrier integrity: Glutamine is the preferred energy substrate for intestinal epithelial cells and plays a critical role in maintaining tight junction proteins (occludin and zonula occludens-1), preventing increased intestinal permeability ("leaky gut") [3][8][9].
• Immune function: Lymphocytes and macrophages utilize glutamine at high rates for nucleotide synthesis, energy production, and cytokine regulation. Glutamine depletion impairs immune cell proliferation and function [1][2][10].
• Nitrogen transport: Glutamine serves as the primary non-toxic nitrogen shuttle between tissues, carrying ammonia from peripheral tissues to the liver (for urea synthesis) and kidneys (for acid-base regulation) [3][11].
• Acid-base homeostasis: In the kidneys, glutaminase converts glutamine to glutamate and ammonium (NH4+), which is excreted in urine to eliminate excess hydrogen ions and generate bicarbonate. This process is upregulated during metabolic acidosis [3][12].
• Biosynthetic precursor: Glutamine provides nitrogen for the synthesis of purines and pyrimidines (DNA and RNA building blocks), hexosamines (glycoproteins and glycolipids), and glutathione (the body's primary intracellular antioxidant) [2][3][13].
• Muscle protein metabolism: Glutamine comprises 5-15% of total free amino acids in skeletal muscle, where concentrations reach approximately 20 mmol/kg wet weight — roughly 30 times higher than in plasma [5][14].

Glutamine is found abundantly in protein-containing foods. An average Western diet supplies approximately 3-10 grams of glutamine per day, depending on total protein intake and food sources [1][2][15]. Supplemental doses in clinical studies typically range from 5-30 grams per day, with the most commonly studied dose for general use being 5-10 grams per day [1][16][17].

The biologically active form is L-glutamine — the form produced by living organisms and the only form found in dietary supplements. The term "glutamine" in this article always refers to L-glutamine [1].

Forms and Bioavailability

Free-Form L-Glutamine

The vast majority of glutamine supplements contain free-form L-glutamine, produced at low cost by industrial fermentation using strains of Corynebacterium glutamicum, from which it is then isolated and purified [1][18]. Free-form L-glutamine is available as:

• Powder: The most common and cost-effective form. Allows flexible dosing. Typically mixed with water or another cold/room-temperature beverage. The powder is a white, odorless, crystalline substance with moderate water solubility (approximately 35 g/L at 20°C) [18][19].
• Capsules: Convenient but require multiple capsules to achieve therapeutic doses (a 5-gram dose would require 10 standard 500 mg capsules), making powder the preferred delivery method for most clinical applications [18].

As long as "L-glutamine" is listed as the ingredient in a supplement, it is in the free form, regardless of whether "free form" is indicated on the label [16].

Dipeptide Forms

In clinical settings, glutamine is sometimes administered intravenously as a dipeptide — most commonly alanyl-glutamine (L-alanyl-L-glutamine) or glycyl-glutamine. These dipeptide forms offer superior stability in solution compared to free glutamine (which degrades over time in liquid, particularly at elevated temperatures) and are the standard for parenteral nutrition supplementation [3][17][20].

Alanyl-glutamine has also been studied as an oral supplement and is available in some commercial products marketed for sports recovery and hydration. It provides glutamine with improved stability in aqueous solutions compared to free-form glutamine [20].

Bioavailability and Absorption

Dietary and supplemental L-glutamine exhibits high oral bioavailability, with absorption occurring predominantly in the small intestine through sodium-dependent amino acid transporters, including SLC1A5 (also known as ASCT2) and members of the SLC38 family (SNAT1, SNAT2, SNAT3) [3][21][22].

A critical consideration is first-pass intestinal metabolism: up to 30% of ingested glutamine is consumed by enterocytes in the intestinal lining before reaching systemic circulation [3][22]. This is not necessarily a "loss" — for applications targeting gut health (such as intestinal permeability or IBS), this first-pass utilization is the therapeutic mechanism of action. However, for applications requiring systemic delivery (such as immune support or muscle recovery), this first-pass extraction means that oral doses must be correspondingly higher to achieve meaningful plasma elevations [3][22].

Stability Considerations

Glutamine is susceptible to degradation in several conditions [16][18][19]:

• Heat: Decomposition accelerates with temperature. Do not mix into hot beverages. Prepare solutions immediately before consumption.
• Acidic or alkaline pH: The amide side chain undergoes hydrolysis to form glutamate in acidic or basic environments. Optimal stability is between pH 5.0 and 7.5.
• Time in solution: Degradation increases with time in liquid form. Do not prepare solutions in advance.
• Moisture: Store in a cool, dry place. Do not discard desiccant packs from containers. Refrigeration is not necessary but may prolong shelf life [16].

At elevated temperatures, glutamine can cyclize to form pyroglutamic acid (5-oxoproline), a degradation product with no therapeutic value [19].

Comparison with Glutamate and MSG

Glutamine is structurally distinct from glutamate (glutamic acid), though the two are closely related metabolically. Glutamine has an amide group on its side chain; glutamate has a carboxylic acid group. In the body, glutaminase converts glutamine to glutamate and ammonia [1][3]. This metabolic relationship is relevant because individuals who are hypersensitive to MSG (monosodium glutamate) may experience symptoms when taking glutamine without food, as some glutamine is converted to glutamate in the gut [16][23].

Evidence for Benefits

Irritable Bowel Syndrome (IBS-D)

The strongest clinical evidence for glutamine supplementation in a non-critical-care setting comes from a randomized controlled trial in diarrhea-predominant IBS (IBS-D).

In a study of 106 men and women (average age 31) with post-infectious IBS-D, Zhou et al. (2018) found that 79.6% of those taking glutamine for two months achieved a clinically significant improvement in symptom severity (greater than 50-point reduction on the IBS Severity Scoring System, which uses a 0-500 scale), compared to just 5.8% of those taking placebo (whey protein) [24].

Key findings from this trial [24]:

• Abdominal pain showed the greatest improvement with glutamine versus placebo
• Bowel movement frequency decreased by 2.5 movements per day in the glutamine group versus no change with placebo
• Quality of life and satisfaction with bowel habits improved significantly
• Intestinal permeability (measured by 24-hour urinary lactulose/mannitol ratio) was restored to normal with glutamine but not with placebo
• Dosing protocol: 5 grams of glutamine powder mixed with 8 ounces of water, taken three times daily (15 grams total per day)

The mechanism underlying this benefit involves glutamine's role as the primary energy substrate for enterocytes and its ability to enhance tight junction protein expression. A 2022 laboratory study demonstrated that glutamine restores tight junction assembly (occludin and zonula occludens-1) disrupted by inflammatory cytokines, supporting epithelial repair and preventing bacterial translocation [8][9].

This trial is notable for its robust design (randomized, double-blind, placebo-controlled), meaningful effect size, and the specificity of the population studied (post-infectious IBS-D with documented increased intestinal permeability). It remains the strongest evidence supporting glutamine for any form of IBS.

Intestinal Permeability ("Leaky Gut")

Beyond IBS, glutamine has been studied for its effects on intestinal barrier function in several contexts.

NSAID-induced permeability: A small study found that taking multiple doses of glutamine around the time of NSAID dosing partly prevented the increase in intestinal permeability caused by indomethacin (75 mg). To be effective, the dosing protocol required glutamine dissolved in water at several timepoints: 7 grams 30 minutes before, 1 gram with, and two additional 1-gram doses after the NSAID (Hond et al., 1999) [25]. Importantly, glutamine did not work when taken only before NSAID dosing (either 1 week prior or even 30 minutes prior to the NSAID alone). There are no published clinical studies investigating whether glutamine supplementation reduces stomach pain, ulceration, or bleeding risk associated with NSAID use [16][25].

Exercise-induced permeability: During prolonged endurance exercise, intestinal permeability can increase due to splanchnic hypoperfusion (reduced blood flow to the gut). Emerging research from 2024-2025 suggests glutamine supplementation may reduce exercise-induced gut permeability and support intestinal barrier function in endurance athletes, though the evidence base remains limited [26][27].

Inflammatory bowel disease (IBD): Systematic reviews through 2021 show mixed results for glutamine in ulcerative colitis and Crohn's disease. Some studies show improvements in intestinal permeability, but glutamine has not consistently demonstrated benefits for disease activity scores, anthropometric measures, or inflammation markers in IBD patients [28][29]. The evidence is insufficient to recommend routine glutamine supplementation for IBD management.

Exercise and Muscle Recovery

Glutamine is one of the most popular sports nutrition supplements, but the evidence for its benefits in healthy, well-nourished athletes is considerably weaker than marketing claims suggest.

Muscle damage markers: A study among professional basketball players found that 6 grams of glutamine daily (as capsules taken every morning) for 20 days reduced blood markers of muscle damage — creatine kinase, myoglobin, and aspartate transaminase — after strenuous exercise compared to placebo (Cordova-Martinez et al., 2021) [30].

Post-exercise infection risk: Prolonged intense exercise can transiently suppress immune function, and glutamine levels in the body may decrease after prolonged exercise. Early research suggested that glutamine supplementation may reduce the incidence of upper respiratory tract infections in athletes who are overtraining (Castell et al., 1996; Walsh et al., 1998) [31][32]. A 2019 review in the Journal of the International Society of Sports Nutrition highlighted glutamine's potential to support immune function during intense training by maintaining mucosal integrity [33].

Performance and body composition: The evidence is clear that glutamine does NOT improve exercise performance in healthy, well-nourished individuals. Meta-analyses and randomized controlled trials consistently show no significant improvements in muscle growth, strength, aerobic performance (including VO2 max), body composition, or lean mass when protein intake is adequate [27][33][34][35]. Some studies suggest minor reductions in muscle damage markers or soreness post-intense exercise, but these do not consistently translate to performance gains [34].

Proposed mechanisms: The theoretical basis for glutamine's exercise benefits includes enhanced cellular hydration in skeletal muscle through osmotic effects and attenuation of post-exercise inflammation by modulating cytokine production and reducing oxidative stress markers [36]. However, direct evidence for these mechanisms translating to meaningful performance benefits remains limited [37].

Practical bottom line: For healthy athletes with adequate protein intake, glutamine supplementation is unlikely to provide meaningful benefits for performance, muscle growth, or recovery. Benefits are most plausible during periods of extremely intense training (e.g., overtraining) where immune suppression and glutamine depletion are more likely, or in endurance athletes concerned about exercise-induced gut permeability [27][31][33].

Oral Mucositis (Chemotherapy-Related)

Glutamine may reduce oral mucositis — painful inflammation and ulceration of the mouth lining — in patients undergoing chemotherapy. This is one of the better-supported clinical applications.

Swish-and-swallow protocol: Peterson et al. (2006) demonstrated benefit with 4 grams of glutamine suspension swished in the mouth and then swallowed every four hours around the clock, starting with the first dose of chemotherapy and continuing until chemotherapy ends or the mouth irritation resolves [38].

Oral dosing protocol: Other studies have shown benefit with 10 grams of glutamine dissolved in water three times daily (30 grams total per day) during chemotherapy cycles (Tsujimoto et al., 2015; Lopez-Vaquero et al., 2017) [39][40].

Chemotherapy-induced peripheral neuropathy: Preliminary evidence suggests oral glutamine at doses of 10-30 grams per day during taxane-based chemotherapy regimens may reduce the severity of peripheral neuropathy (nerve damage causing tingling, numbness, and pain in the hands and feet), though this evidence is primarily from earlier trials and requires further confirmation [41][42].

These applications should only be undertaken under the guidance of an oncologist, as glutamine's role in cancer metabolism introduces theoretical concerns about tumor support (see Cancer Metabolism section below).

Sickle Cell Disease

L-glutamine (branded as Endari) is the only FDA-approved pharmaceutical application of glutamine. It is approved for reducing acute complications of sickle cell disease in adults and children aged 5 years and older [43].

In a phase 3 randomized controlled trial involving 230 patients with sickle cell anemia or sickle beta-zero-thalassemia, oral L-glutamine at a dose of 0.3 g/kg/day (divided into two administrations) produced the following results compared to placebo [43][44]:

• Median painful vaso-occlusive crises: 3.0 per year versus 4.0 (25% reduction)
• Median hospitalizations: 2.0 per year versus 3.0

Earlier phase 2 trials demonstrated that oral glutamine improved red blood cell NAD+ levels, which is believed to reduce oxidative stress in sickle cells and thereby decrease the frequency of sickling events [44][45].

Pediatric dosing data have expanded since 2023, with 2024 trials confirming safety in children with sickle cell disease at oral doses of 5-10 g/day (or up to 0.7 g/kg/day) [46].

Critical Care and Surgical Recovery

Glutamine supplementation in critically ill patients has a complex and evolving evidence base.

Early positive evidence: Meta-analyses from the 2000s and early 2010s indicated that intravenous glutamine at 0.3-0.5 g/kg/day, administered as part of parenteral nutrition, was associated with reduced mortality and infectious complications in select critically ill populations [47][48].

REDOXS trial — a cautionary result: The landmark REDOXS trial (2013) fundamentally changed clinical practice. This large trial showed no mortality benefit from glutamine supplementation and raised safety concerns: the glutamine group had higher 28-day mortality (32%) compared to placebo (25%) in patients with multiorgan failure [49]. The META-PLUS trial (2014) similarly showed mixed results [50].

Current guidelines: These findings led to substantial revisions in clinical recommendations. The 2019 ESPEN guidelines endorse glutamine supplementation (0.3-0.5 g/kg/day) only in stressed ICU patients without organ failure, such as those with burns or stable trauma [51]. ESPEN guidelines (2023) caution against use in severe liver failure due to risks of hyperammonemia [52]. The A.S.P.E.N. 2016 guidelines conditionally recommend glutamine at 0.2-0.3 g/kg/day only in select patients receiving full nutrition support [17].

Perioperative supplementation: Glutamine at 20-30 g/day via enteral or parenteral routes has demonstrated benefits in surgical recovery. A 2020 systematic review in hepatectomy patients found that immunonutrition regimens including glutamine shortened hospital stays and lowered infection rates compared to standard care [53].

HIV/AIDS Wasting

A 1999 randomized, double-blind controlled trial of 26 AIDS patients (21 completed) with greater than 5% weight loss found that a glutamine-antioxidant mixture at 40 g/day glutamine increased body weight by 2.2 kg over 12 weeks, compared to 0.3 kg in the placebo group, while also enhancing nutritional status [54]. Glutamine's proposed mechanism involves replenishing glutathione stores and supporting T-cell proliferation amid chronic immune activation [55].

Cancer Cachexia

Glutamine supplementation has been explored to preserve skeletal muscle mass and mitigate cancer-related wasting. Reviews and animal studies indicate potential benefits in supporting protein synthesis and countering hypercatabolism, though human evidence from randomized trials is limited and shows mixed results. Current oncology guidelines (including ASCO 2020) do not strongly recommend glutamine for cancer cachexia [56][57].

Long COVID Fatigue

Emerging investigations from 2023-2025 have examined glutamine depletion as a factor in long COVID-related fatigue. Small trials suggest benefits from supplementation at 10 g/day, with reports of improved energy levels and reduced symptom severity, potentially due to glutamine's role in immune modulation and muscle repair. However, larger validation studies are needed before recommendations can be made [58][59].

Cancer Metabolism — An Important Caveat

While glutamine is being studied for reducing chemotherapy side effects, a significant concern exists regarding its potential to support tumor growth. Many cancer cells exhibit "glutamine addiction" — they rely heavily on exogenous glutamine to fuel biosynthetic pathways, energy production, and redox balance [60][61].

This dependency was first discovered in 1955 by Harry Eagle, who observed that cancer cells in culture required exceptionally high concentrations of glutamine to survive and proliferate. Modern studies confirm that many cancers overexpress glutaminase (GLS), which converts glutamine to glutamate, supporting the TCA cycle and providing precursors for nucleotides, amino acids, and lipids essential for rapid cell division [60][61].

This understanding has led to the opposite therapeutic approach — glutamine deprivation as a cancer treatment. Telaglenastat (CB-839), a selective glutaminase inhibitor, has been evaluated in Phase I/II trials from 2023-2025 in combination with immunotherapies for melanoma, renal cell carcinoma, and non-small cell lung cancer, with ongoing Phase III trials [62][63].

The clinical implication for supplementation is that individuals with active cancer should not take glutamine supplements without explicit approval from their oncologist, as supplementation could theoretically fuel tumor growth in glutamine-dependent cancers [60][64].

Recommended Dosing

General Dosing Guidelines

Glutamine does not have an established Recommended Dietary Allowance (RDA) because it is classified as a non-essential amino acid — the body produces sufficient amounts under normal conditions [2][22]. An average diet supplies 3-10 grams per day from protein-containing foods [1][2][15].

Dosing by Indication

Indication	Dose	Duration	Notes
IBS-D (post-infectious)	5 g three times daily (15 g/day)	8 weeks	Mix powder in water. Best-supported clinical dose [24]
NSAID-induced permeability	7 g before + 1 g with + 2 g after NSAID	Acute use	Must be timed around NSAID doses [25]
Oral mucositis (chemotherapy)	4 g swish-and-swallow every 4 hours, OR 10 g three times daily	During chemotherapy	Under oncologist supervision only [38][39][40]
Sickle cell disease (Endari)	0.3 g/kg/day in 2 divided doses	Ongoing	FDA-approved. Up to 10 g per dose for patients over 65 kg [43][44]
Critical care (parenteral)	0.2-0.5 g/kg/day IV	During ICU stay	Only in patients without organ failure [17][51]
Perioperative recovery	20-30 g/day (enteral or parenteral)	Perioperative period	Evidence for reduced infection and shorter hospital stay [53]
Exercise recovery/immune support	5-10 g/day	During heavy training	Limited evidence; most beneficial during overtraining periods [16][33]
General supplementation	5-10 g/day	Variable	No clear evidence of benefit in healthy individuals with adequate protein intake [27][34]

Practical Dosing Notes

• Powder is preferred over capsules for therapeutic doses. A 5-gram dose requires only one teaspoon of powder versus ten 500-mg capsules [16][18].
• Divide doses throughout the day for doses exceeding 10 grams per day to minimize gastrointestinal side effects [16][17].
• Timing for exercise: Post-workout timing is commonly recommended. Animal studies suggest post-exercise supplementation may reduce muscle damage more effectively than pre-exercise administration [65][66].
• Timing for gut health: Taking glutamine on an empty stomach may optimize delivery to the intestinal lining; alternatively, take with meals to minimize GI discomfort [65][66].
• Dissolve in cold or room-temperature water only. Never mix into hot beverages, as heat accelerates degradation. Prepare solutions immediately before consumption [16][19].

Pediatric Dosing

L-glutamine is considered safe in children at doses up to 0.7 g/kg body weight per day, supported by clinical trial data in sickle cell disease. In low-birth-weight infants receiving parenteral nutrition, doses of 0.3-0.6 g/kg/day have been studied. Routine supplementation is not recommended for healthy children or adolescents without medical indication [46][67].

Safety and Side Effects

General Safety Profile

At recommended dosages (5-10 g/day), glutamine is generally well tolerated. The U.S. FDA recognizes L-glutamine as generally recognized as safe (GRAS) for use in food as a nutrient or dietary supplement [68]. The supplement has low acute toxicity, with an oral LD50 exceeding 16 g/kg in rats [69].

Common Side Effects

The most frequently reported side effects are gastrointestinal in nature, typically occurring at doses of 10 grams or more per day [16][23][69]:

• Nausea: Reported in 13-31% of users (particularly at higher doses)
• Abdominal pain: Reported in 11-25% of users
• Vomiting: Reported in 11-19% of users
• Bloating and gas
• Diarrhea: More common at doses exceeding 20 g/day
• Constipation

These side effects are generally dose-dependent and resolve with dose reduction or discontinuation.

MSG Sensitivity

In people who are hypersensitive to MSG (monosodium glutamate), consuming 3 grams or more of glutamine without food can cause symptoms including headache, nausea, flushing, and anxiety. This occurs because glutamine is partially converted to glutamate in the gut [16][23][70].

Higher-Dose Side Effects (30+ g/day)

At daily doses of 30 grams or more, additional side effects have been reported [16][71]:

• Dry mouth
• Headache
• Dizziness

In one case, dizziness resolved when the daily dose was reduced from approximately 34 grams to 17 grams per day [71].

Kidney Injury

Glutamine supplementation may rarely cause kidney injury, particularly in individuals with pre-existing kidney disease. A case report described a 77-year-old man with chronic kidney disease who developed excessive thirst, frequent urination, and acute kidney injury after taking 18 grams of L-glutamine daily for six months [72]. The proposed mechanism involves L-glutamine breakdown in the kidneys producing ammonia — high levels of which can cause tubular damage. Kidney biopsy results were consistent with ammonia-induced injury [72].

Recommendation: Individuals with chronic kidney disease should monitor kidney function monthly for 3 to 4 months when starting L-glutamine supplements. Those with advanced kidney disease (CKD stage 4-5) should avoid glutamine supplementation entirely unless under direct medical supervision [72][73].

Psychiatric Effects

Glutamine supplementation of up to 4 grams per day was reported to trigger mania in two people with bipolar disorder (Mebane, 1984) [74]. Individuals with bipolar disorder should exercise caution with glutamine supplementation.

Epilepsy Concerns

Based on animal and laboratory studies, there is theoretical concern that glutamine may interfere with anti-epilepsy drugs by altering glutamate-glutamine cycling in the brain. While this has not been confirmed in human studies, individuals with epilepsy should consult their neurologist before supplementing with glutamine [16][75][76].

Hepatic Encephalopathy and Liver Disease

Glutamine should be used with extreme caution — or avoided entirely — in patients with severe liver disease. Glutamine is metabolized to ammonia, and the liver is responsible for converting ammonia to urea for excretion. In liver failure, this pathway is impaired, and glutamine supplementation can exacerbate hyperammonemia. The 2023 ESPEN guidelines specifically caution against glutamine use in severe liver failure [49][52][73].

Cancer Safety Considerations

As discussed in the Evidence for Benefits section, glutamine supplementation raises theoretical concerns about promoting tumor growth in glutamine-dependent cancers. While glutamine is used therapeutically to reduce chemotherapy side effects, patients with active cancer should only use glutamine under oncologist supervision [60][64].

Safety in Pregnancy and Lactation

There are insufficient data on the safety of glutamine supplementation during pregnancy and lactation. Human breast milk naturally contains approximately 0.08 g of glutamine per 100 mL [22]. Pregnant and lactating women should consult their healthcare provider before supplementing.

Tolerability at High Doses

In the context of exercise and general supplementation, glutamine is generally well tolerated at doses up to 40 grams per day for short-term use, though mild GI side effects increase with dose [69][77]. The FDA-approved dose for sickle cell disease (0.3 g/kg/day, up to approximately 21 g/day for a 70-kg adult) has been studied for safety in controlled trials [43][44].

Drug Interactions

Medications That May Interact with Glutamine

Drug	Interaction	Clinical Implication
Methotrexate	Glutamine may reduce GI toxicity but may also decrease systemic clearance of methotrexate, leading to higher drug exposure [78][79]	Use only under oncologist supervision
Anti-epilepsy drugs	Theoretical concern that glutamine may interfere with seizure control by altering glutamate-glutamine cycling [16][75]	Consult neurologist before supplementing
Lactulose	Lactulose reduces ammonia in hepatic encephalopathy; glutamine may counteract this by increasing ammonia production [73]	Avoid concurrent use in patients on lactulose for hepatic encephalopathy
Chemotherapy agents	Complex: glutamine may reduce mucosal toxicity (beneficial) but could theoretically support tumor growth (harmful) [38][60]	Use only under oncologist supervision

Amino Acid Competition

Glutamine competes with other amino acids — including leucine and asparagine — for transport across cell membranes via shared carriers such as SNAT1 and ASCT2 [80]. This competition may theoretically affect uptake of other amino acids when glutamine is taken at high doses, though the clinical significance of this interaction at standard supplemental doses is unclear.

Monitoring Recommendations

• Plasma glutamine levels: Normal fasting range is 420-750 micromolar. Levels below 420 micromolar may indicate deficiency in critical illness; levels above 800 micromolar warrant caution [6].
• Kidney function: Monitor creatinine and BUN in patients with pre-existing kidney disease who start glutamine supplementation [72].
• Liver function and ammonia: Monitor in patients with liver disease [52][73].

Dietary Sources

Glutamine is abundant in protein-rich foods, where it typically constitutes 4-6% of total amino acids in animal proteins and 3-5% in plant proteins [2][15][81].

Top Food Sources

Food	Serving	Approximate Glutamine (g)	Notes
Beef	100 g (3.5 oz)	1.2	One of the richest animal sources
Chicken	100 g (3.5 oz)	1.0	Comparable to other poultry
Turkey	100 g (3.5 oz)	1.0
Pork	100 g (3.5 oz)	1.1
Fish and seafood	100 g (3.5 oz)	0.8-1.0	Shellfish particularly rich
Eggs	2 large	0.6
Milk	250 mL (1 cup)	0.6
Yogurt	200 g	0.5
Cheese (cottage/ricotta)	100 g	0.5-0.8
Wheat germ	100 g	Up to 9.5	Extremely concentrated plant source
Kidney beans	100 g cooked	0.5-0.8	Best legume source
Spinach	100 g raw	0.3	Highest among leafy greens
Cabbage	100 g raw	0.3	Traditional folk remedy for gut health
Parsley	100 g	0.3

Sources: Grokipedia [3], ConsumerLab [16], dietary glutamine composition databases [15][81].

Practical Notes on Dietary Glutamine

• Omnivore diets typically provide 5-10 grams of glutamine per day; vegetarian diets may provide 3-5 grams per day due to lower total protein intake and different protein sources [22].
• Cooking and processing can reduce glutamine content, as heat promotes the conversion of glutamine to glutamate and pyroglutamic acid [19].
• Protein-rich diet may be sufficient: For healthy individuals not in a catabolic state, a diet providing adequate protein (0.8-1.2 g/kg/day) likely supplies sufficient glutamine without supplementation [2][22][34].
• Human breast milk contains approximately 0.08 g of glutamine per 100 mL, primarily bound in proteins, providing neonates with 0.4-0.8 grams daily from typical volumes consumed [22].

Special Dietary Considerations

Individuals in catabolic states (trauma, surgery, burns, critical illness, intense prolonged exercise) may benefit from additional glutamine beyond what diet provides, as the body's requirements in these conditions can exceed both endogenous synthesis and dietary intake [1][4][5]. In these situations, supplementation at therapeutic doses may be warranted under medical supervision.

References

1. Cruzat V, Macedo Rogero M, Noel Keane K, et al. "Glutamine: Metabolism and Immune Function, Supplementation and Clinical Translation." Nutrients. 2018;10(11):1564. https://doi.org/10.3390/nu10111564

2. Lacey JM, Wilmore DW. "Is glutamine a conditionally essential amino acid?" Nutr Rev. 1990;48(8):297-309. https://pubmed.ncbi.nlm.nih.gov/2080048/

3. Grokipedia. "Glutamine." https://grokipedia.com/page/Glutamine

4. Wernerman J. "Clinical use of glutamine supplementation." J Nutr. 2008;138(10):2040S-2044S. https://doi.org/10.1093/jn/138.10.2040S

5. Newsholme P, Procopio J, Lima MMR, et al. "Glutamine and glutamate—their central role in cell metabolism and function." Cell Biochem Funct. 2003;21(1):1-9. https://doi.org/10.1002/cbf.1003

6. Rodas PC, Rooyackers O, Hebert C, et al. "Glutamine and glutathione at ICU admission in relation to outcome." Clin Sci. 2012;122(12):591-597. https://doi.org/10.1042/CS20110520

7. Windmueller HG, Spaeth AE. "Intestinal metabolism of glutamine and glutamate from the lumen as compared to glutamine from blood." Arch Biochem Biophys. 1975;171(2):662-672. https://doi.org/10.1016/0003-9861(75)90078-8

8. Li N, Neu J. "Glutamine deprivation alters intestinal tight junctions via a PI3-K/Akt mediated pathway in Caco-2 cells." J Nutr. 2009;139(4):710-714. https://doi.org/10.3945/jn.108.101485

9. Rao R, Samak G. "Role of Glutamine in Protection of Intestinal Epithelial Tight Junctions." J Epithel Biol Pharmacol. 2012;5(Suppl 1-M7):47-54. https://doi.org/10.2174/1875044301205010047

10. Calder PC, Yaqoob P. "Glutamine and the immune system." Amino Acids. 1999;17(3):227-241. https://doi.org/10.1007/BF01366922

11. Brosnan JT. "Interorgan amino acid transport and its regulation." J Nutr. 2003;133(6 Suppl 1):2068S-2072S. https://doi.org/10.1093/jn/133.6.2068S

12. Weiner ID, Verlander JW. "Renal ammonia metabolism and transport." Compr Physiol. 2013;3(1):201-220. https://doi.org/10.1002/cphy.c120010

13. DeBerardinis RJ, Cheng T. "Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer." Oncogene. 2010;29(3):313-324. https://doi.org/10.1038/onc.2009.358

14. Bergstrom J, Furst P, Noree LO, et al. "Intracellular free amino acid concentration in human muscle tissue." J Appl Physiol. 1974;36(6):693-697. https://doi.org/10.1152/jappl.1974.36.6.693

15. Lenders CM, Liu S, Wilmore DW, et al. "Evaluation of a novel food composition database that includes glutamine and other amino acids derived from gene sequencing data." Eur J Clin Nutr. 2009;63(12):1433-1439. https://doi.org/10.1038/ejcn.2009.110

16. ConsumerLab. "Glutamine Supplements Review." Accessed 2026. https://www.consumerlab.com/reviews/glutamine-review-comparisons/glutamine/

17. McClave SA, Taylor BE, Martindale RG, et al. "Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: A.S.P.E.N." JPEN J Parenter Enteral Nutr. 2016;40(2):159-211. https://doi.org/10.1177/0148607115621863

18. Isao O. "Production of glutamine by fermentation." J Nutr. 2001;131(9 Suppl):2552S-2555S.

19. Degradation kinetics of L-glutamine in aqueous solution. As referenced in Grokipedia [3]. Optimal stability at pH 5.0-7.5.

20. Furst P, Pogan K, Stehle P. "Glutamine dipeptides in clinical nutrition." Nutrition. 1997;13(7-8):731-737. https://doi.org/10.1016/S0899-9007(97)83035-3

21. Pochini L, Scalise M, Galluccio M, Indiveri C. "Membrane transporters for the special amino acid glutamine." Front Chem. 2014;2:61. https://doi.org/10.3389/fchem.2014.00061

22. Grokipedia. "Glutamine — Dietary Intake and Requirements." https://grokipedia.com/page/Glutamine

23. Ogden HB, et al. "Gastrointestinal Tolerance of Low, Medium, and High Dose Acute Oral L-Glutamine Supplementation in Healthy Adults." Nutrients. 2020;12(7):2136. https://doi.org/10.3390/nu12072136

24. Zhou Q, Verne ML, Fields JZ, et al. "Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome." Gut. 2019;68(6):996-1002. https://doi.org/10.1136/gutjnl-2017-315136

25. Hond ED, Peeters M, Hiele M, et al. "Effect of glutamine on the intestinal permeability changes induced by indomethacin in humans." Aliment Pharmacol Ther. 1999;13(5):679-685. https://doi.org/10.1046/j.1365-2036.1999.00523.x

26. Pugh JN, Sage S, Hutber M, et al. "Glutamine supplementation reduces markers of intestinal permeability during running in the heat." Eur J Appl Physiol. 2017;117(12):2569-2577. https://doi.org/10.1007/s00421-017-3744-4

27. Grokipedia. "Glutamine — Supplementation in Health and Exercise." https://grokipedia.com/page/Glutamine

28. Grokipedia. "Glutamine — Inflammatory Bowel Disease." https://grokipedia.com/page/Glutamine

29. Akobeng AK, et al. "Glutamine for induction of remission in Crohn's disease." Cochrane Database Syst Rev. 2016. https://doi.org/10.1002/14651858.CD007348.pub2

30. Cordova-Martinez A, et al. "Effect of Glutamine Supplementation on Muscular Damage Biomarkers in Professional Basketball Players." Nutrients. 2021;13(6):2073. https://doi.org/10.3390/nu13062073

31. Castell LM, et al. "Does glutamine have a role in reducing infections in athletes?" Eur J Appl Physiol Occup Physiol. 1996;73(5):488-490. https://doi.org/10.1007/BF00334429

32. Walsh NP, et al. "Glutamine, exercise and immune function." Sports Med. 1998;26(3):177-191. https://doi.org/10.2165/00007256-199826030-00004

33. Gleeson M. "Dosing and Efficacy of Glutamine Supplementation in Human Exercise and Sport Training." J Nutr. 2008;138(10):2045S-2049S. https://doi.org/10.1093/jn/138.10.2045S

34. Ramezani Ahmadi A, et al. "The effect of glutamine supplementation on athletic performance, body composition, and immune function." Clin Nutr. 2019;38(3):1076-1091. https://doi.org/10.1016/j.clnu.2018.05.001

35. Candow DG, et al. "Effect of glutamine supplementation combined with resistance training in young adults." Eur J Appl Physiol. 2001;86(2):142-149. https://doi.org/10.1007/s00421-001-0523-y

36. Legault Z, et al. "The influence of oral L-glutamine supplementation on muscle strength recovery and soreness." Int J Sport Nutr Exerc Metab. 2015;25(5):417-426. https://doi.org/10.1123/ijsnem.2014-0209

37. Gleeson M. "Interrelationship between physical activity and branched-chain amino acids." J Nutr. 2005;135(6 Suppl):1591S-1595S.

38. Peterson DE, et al. "Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis." Cancer. 2007;109(2):322-331. https://doi.org/10.1002/cncr.22384

39. Tsujimoto T, et al. "L-glutamine decreases the severity of mucositis induced by chemoradiotherapy." Oncol Rep. 2015;33(1):33-39. https://doi.org/10.3892/or.2014.3564

40. Lopez-Vaquero D, et al. "Double-blind randomized study of oral glutamine on the management of radio/chemotherapy-induced mucositis." Mol Clin Oncol. 2017;6(6):931-936. https://doi.org/10.3892/mco.2017.1238

41. Grokipedia. "Glutamine — Chemotherapy-Induced Peripheral Neuropathy." https://grokipedia.com/page/Glutamine

42. Vahdat L, et al. "Reduction of paclitaxel-induced peripheral neuropathy with glutamine." Clin Cancer Res. 2001;7(5):1192-1197. https://pubmed.ncbi.nlm.nih.gov/11350883/

43. Endari (glutamine) prescribing information. Emmaus Medical Inc. FDA-approved July 2017. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208587s000lbl.pdf

44. Niihara Y, et al. "A Phase 3 Trial of L-Glutamine in Sickle Cell Disease." N Engl J Med. 2018;379(3):226-235. https://doi.org/10.1056/NEJMoa1715971

45. Niihara Y, et al. "Oral L-glutamine therapy for sickle cell anemia." Am J Hematol. 1998;58(2):117-121. https://pubmed.ncbi.nlm.nih.gov/9625578/

46. Grokipedia. "Glutamine — Pediatric Dosing." https://grokipedia.com/page/Glutamine

47. Novak F, et al. "Glutamine supplementation in serious illness: a systematic review." Crit Care Med. 2002;30(9):2022-2029. https://doi.org/10.1097/00003246-200209000-00011

48. Wischmeyer PE, et al. "Parenteral glutamine supplementation in critical illness: a systematic review." Crit Care. 2014;18(2):R76. https://doi.org/10.1186/cc13836

49. Heyland D, et al. "A randomized trial of glutamine and antioxidants in critically ill patients (REDOXS)." N Engl J Med. 2013;368(16):1489-1497. https://doi.org/10.1056/NEJMoa1212722

50. van Zanten ARH, et al. "High-protein enteral nutrition enriched with immune-modulating nutrients vs standard (META-PLUS)." JAMA. 2014;312(5):514-524. https://doi.org/10.1001/jama.2014.7024

51. Singer P, et al. "ESPEN guideline on clinical nutrition in the intensive care unit." Clin Nutr. 2019;38(1):48-79. https://doi.org/10.1016/j.clnu.2018.08.037

52. Grokipedia. "Glutamine — ESPEN Guidelines 2023." https://grokipedia.com/page/Glutamine

53. Grokipedia. "Glutamine — Perioperative Immunonutrition." 2020 systematic review in hepatectomy patients. https://grokipedia.com/page/Glutamine

54. Shabert JK, et al. "Glutamine-antioxidant supplementation increases body cell mass in AIDS patients with weight loss." Nutrition. 1999;15(11-12):860-864. https://doi.org/10.1016/S0899-9007(99)00213-0

55. Newsholme P. "Why is L-glutamine metabolism important to cells of the immune system?" J Nutr. 2001;131(9 Suppl):2515S-2522S. https://doi.org/10.1093/jn/131.9.2515S

56. Laviano A, et al. "Nutritional Interventions in Cancer Cachexia." Front Nutr. 2020.

57. Roeland EJ, et al. "Management of Cancer Cachexia: ASCO Guideline." J Clin Oncol. 2020;38(21):2438-2453. https://doi.org/10.1200/JCO.20.00611

58. Grokipedia. "Glutamine — Long COVID." https://grokipedia.com/page/Glutamine

59. Cengiz M, et al. "Effect of oral L-glutamine supplementation on Covid-19 treatment." Clin Nutr Exp. 2020;33:24-31. https://doi.org/10.1016/j.yclnex.2020.07.003

60. Wise DR, Thompson CB. "Glutamine addiction: a new therapeutic target in cancer." Trends Biochem Sci. 2010;35(8):427-433. https://doi.org/10.1016/j.tibs.2010.05.003

61. Altman BJ, et al. "From Krebs to clinic: glutamine metabolism to cancer therapy." Nat Rev Cancer. 2016;16(10):619-634. https://doi.org/10.1038/nrc.2016.71

62. Grokipedia. "Glutamine — Telaglenastat (CB-839)." https://grokipedia.com/page/Glutamine

63. Harding JJ, et al. "Safety and tolerability of CB-839, a glutaminase inhibitor, in solid tumors." J Clin Oncol. 2015;33(15_suppl):2512. https://doi.org/10.1200/jco.2015.33.15_suppl.2512

64. National Cancer Institute. "Nutrition in Cancer Care (PDQ) — Health Professional Version." https://www.cancer.gov/about-cancer/treatment/side-effects/appetite-loss/nutrition-hp-pdq

65. Grokipedia. "Glutamine — Timing and Dosing." https://grokipedia.com/page/Glutamine

66. Raizel R, et al. "Anti-inflammatory and cytoprotective effects of L-glutamine and L-alanine supplementation in rats." Br J Nutr. 2016;116(3):470-479. https://doi.org/10.1017/S0007114516001999

67. Grokipedia. "Glutamine — Pediatric Dosing." https://grokipedia.com/page/Glutamine

68. U.S. FDA. "GRAS Notice No. GRN 000019: L-Glutamine." https://www.fda.gov/food/generally-recognized-safe-gras/gras-notice-inventory

69. Grokipedia. "Glutamine — Safety and Toxicology." https://grokipedia.com/page/Glutamine

70. Brandley ET, et al. "The role of glutamate and glutamine in the gut." Front Psychiatry. 2022. https://doi.org/10.3389/fpsyt.2022.871946

71. Nutrastore Prescribing Information 2004; Laviano et al., Eur J Clin Nutrition 2014.

72. Bhoelan S, et al. "L-Glutamine-Induced Acute Kidney Injury: A Clinical Case." Nephron. 2025. https://doi.org/10.1159/000548247

73. Grokipedia. "Glutamine — Kidney and Liver Safety." https://grokipedia.com/page/Glutamine

74. Mebane AH. "L-glutamine and mania." Am J Psychiatry. 1984;141(10):1302-1303. https://doi.org/10.1176/ajp.141.10.1302

75. Chapman AG, et al. "Glutamine and epilepsy." J Nutr. 2000;130(4S Suppl):1043S-1045S.

76. Grokipedia. "Glutamine — Epilepsy Concerns." https://grokipedia.com/page/Glutamine

77. Grokipedia. "Glutamine — Exercise Tolerability." https://grokipedia.com/page/Glutamine

78. Rubio IT, et al. "Effect of glutamine on methotrexate efficacy and toxicity." Ann Surg. 1998;227(5):772-778. https://doi.org/10.1097/00000658-199805000-00018

79. Fox AD, et al. "Effect of a glutamine-supplemented enteral diet on methotrexate-induced enterocolitis." JPEN. 1988;12(4):325-331. https://doi.org/10.1177/0148607188012004325

80. Pochini L, et al. "Glutamine transport. From energy supply to sensing and beyond." Biochim Biophys Acta. 2014;1848(9):2569-2577. https://doi.org/10.1016/j.bbamem.2014.12.015

81. Grokipedia. "Glutamine — Dietary and Commercial Sources." https://grokipedia.com/page/Glutamine